PhRMA Donut Hole Pledge Sets Nice Tone, But Negotiations Continue On $80 Bil. Contribution
This article was originally published in The Pink Sheet Daily
Executive Summary
Higher drug rebates to Medicaid, Medicare under discussion, as are savings from follow-on biologics.